Combining randomized and non-randomized evidence in network meta-analysis

Author:

Efthimiou Orestis1,Mavridis Dimitris12,Debray Thomas P. A.34ORCID,Samara Myrto5,Belger Mark6,Siontis George C. M.7,Leucht Stefan5,Salanti Georgia189,

Affiliation:

1. Department of Hygiene and Epidemiology; University of Ioannina School of Medicine; Ioannina Greece

2. Department of Primary Education; University of Ioannina; Ioannina Greece

3. Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht; Utrecht The Netherlands

4. Cochrane Netherlands, Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht; Utrecht The Netherlands

5. Department of Psychiatry and Psychotherapy; Technische Universität München; München Germany

6. Eli Lilly and Company; Lilly Research Centre; Windlesham U.K.

7. Department of Cardiology; Bern University Hospital; Bern Switzerland

8. Institute of Social and Preventive Medicine; University of Bern; Bern Switzerland

9. Berner Institut für Hausarztmedizin (BIHAM); University of Bern; Bern Switzerland

Funder

Innovative Medicines Initiative Joint Undertaking

European Union's Seventh Framework Programme

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference63 articles.

1. An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions;Reeves;Research Synthesis Methods,2013

2. Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions;Schünemann;Research Synthesis Methods,2013

3. Faria R Hernadez Alava M Manca A Wailoo AJ The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data NICE DSU technical support document 17 2015 http://www.nicedsu.org.uk/Observational-data-TSD (2973296).htm

4. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities;Cameron;Systematic Reviews,2015

5. Bell H Wailoo AJ Hernandez M Grieve R Faria R Gibson L Grimm S The use of real world data for the estimation of treatment effects in NICE decision making NICE DSU technical support document 2016 http://www.nicedsu.org.uk/Real-World-Data-RWD (3026863).htm

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3